Based within the UK DRI at UCL, the Fluid Biomarker Lab was set up in 2021 with a vision to create a biomarker platform for the UK DRI and the wider neurodegenerative disease research community that can undertake the larger studies to inform dementia research, clinical trial set-up, and treatments for all neurodegenerative diseases.
UK DRI , UK DRI at UCL, Queen Square- On site